nodes	percent_of_prediction	percent_of_DWPC	metapath
Pancuronium—BCHE—breast cancer	0.655	1	CbGaD
Pancuronium—BCHE—Irinotecan—breast cancer	0.019	0.541	CbGbCtD
Pancuronium—SLC22A2—Vinblastine—breast cancer	0.0161	0.459	CbGbCtD
Pancuronium—CHRM3—muscle of abdomen—breast cancer	0.00837	0.257	CbGeAlD
Pancuronium—Anaphylactoid reaction—Fluoxymesterone—breast cancer	0.00461	0.0323	CcSEcCtD
Pancuronium—Salivation—Irinotecan—breast cancer	0.00386	0.027	CcSEcCtD
Pancuronium—CHRNA2—mammary gland—breast cancer	0.00368	0.113	CbGeAlD
Pancuronium—Respiratory failure—Ixabepilone—breast cancer	0.00335	0.0235	CcSEcCtD
Pancuronium—Redness—Tamoxifen—breast cancer	0.00314	0.022	CcSEcCtD
Pancuronium—Paralysis—Tamoxifen—breast cancer	0.00305	0.0214	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Anastrozole—breast cancer	0.00232	0.0163	CcSEcCtD
Pancuronium—Drug interaction—Tamoxifen—breast cancer	0.00229	0.016	CcSEcCtD
Pancuronium—Pipecuronium—BCHE—breast cancer	0.0022	0.706	CrCbGaD
Pancuronium—Anaphylactic shock—Fluoxymesterone—breast cancer	0.00219	0.0154	CcSEcCtD
Pancuronium—Muscular weakness—Ixabepilone—breast cancer	0.00211	0.0148	CcSEcCtD
Pancuronium—Respiratory failure—Vinorelbine—breast cancer	0.00185	0.0129	CcSEcCtD
Pancuronium—Redness—Paclitaxel—breast cancer	0.00181	0.0127	CcSEcCtD
Pancuronium—Hypersensitivity—Fluoxymesterone—breast cancer	0.00162	0.0113	CcSEcCtD
Pancuronium—Drug interaction—Gemcitabine—breast cancer	0.00157	0.011	CcSEcCtD
Pancuronium—Anaphylactic shock—Lapatinib—breast cancer	0.00156	0.0109	CcSEcCtD
Pancuronium—CHRNA1—endocrine gland—breast cancer	0.00155	0.0477	CbGeAlD
Pancuronium—CHRNB1—adipose tissue—breast cancer	0.00154	0.0473	CbGeAlD
Pancuronium—Redness—Docetaxel—breast cancer	0.00153	0.0107	CcSEcCtD
Pancuronium—Respiratory failure—Gemcitabine—breast cancer	0.00148	0.0104	CcSEcCtD
Pancuronium—Salivary hypersecretion—Irinotecan—breast cancer	0.00145	0.0102	CcSEcCtD
Pancuronium—Flushing—Letrozole—breast cancer	0.00144	0.0101	CcSEcCtD
Pancuronium—CHRNB1—adrenal gland—breast cancer	0.00138	0.0424	CbGeAlD
Pancuronium—Flushing—Idarubicin—breast cancer	0.00137	0.00961	CcSEcCtD
Pancuronium—Flushing—Raloxifene—breast cancer	0.00137	0.00961	CcSEcCtD
Pancuronium—Erythema—Anastrozole—breast cancer	0.00136	0.0095	CcSEcCtD
Pancuronium—Drug interaction—Paclitaxel—breast cancer	0.00132	0.00922	CcSEcCtD
Pancuronium—CHRNB1—female gonad—breast cancer	0.00129	0.0396	CbGeAlD
Pancuronium—CHRNA2—endocrine gland—breast cancer	0.00129	0.0395	CbGeAlD
Pancuronium—Bronchospasm—Melphalan—breast cancer	0.00128	0.00898	CcSEcCtD
Pancuronium—Respiratory failure—Paclitaxel—breast cancer	0.00124	0.00871	CcSEcCtD
Pancuronium—BCHE—nipple—breast cancer	0.00121	0.037	CbGeAlD
Pancuronium—Muscular weakness—Vinorelbine—breast cancer	0.00116	0.00814	CcSEcCtD
Pancuronium—Hypersensitivity—Lapatinib—breast cancer	0.00115	0.00804	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Irinotecan—breast cancer	0.00112	0.00787	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Mitoxantrone—breast cancer	0.00112	0.00787	CcSEcCtD
Pancuronium—Bronchospasm—Vinorelbine—breast cancer	0.00112	0.00785	CcSEcCtD
Pancuronium—Drug interaction—Docetaxel—breast cancer	0.00112	0.00781	CcSEcCtD
Pancuronium—Anaphylactic shock—Anastrozole—breast cancer	0.00111	0.00775	CcSEcCtD
Pancuronium—Anaphylactic shock—Letrozole—breast cancer	0.00111	0.00775	CcSEcCtD
Pancuronium—Hypotension—Ixabepilone—breast cancer	0.0011	0.00769	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Gemcitabine—breast cancer	0.00109	0.00766	CcSEcCtD
Pancuronium—Tachycardia—Letrozole—breast cancer	0.00108	0.00756	CcSEcCtD
Pancuronium—Paralysis—Methotrexate—breast cancer	0.00107	0.00752	CcSEcCtD
Pancuronium—Hypersensitivity—Fulvestrant—breast cancer	0.00106	0.0074	CcSEcCtD
Pancuronium—Respiratory failure—Docetaxel—breast cancer	0.00105	0.00738	CcSEcCtD
Pancuronium—Anaphylactic shock—Idarubicin—breast cancer	0.00105	0.00736	CcSEcCtD
Pancuronium—Redness—Epirubicin—breast cancer	0.00103	0.00724	CcSEcCtD
Pancuronium—Paralysis—Epirubicin—breast cancer	0.001	0.00704	CcSEcCtD
Pancuronium—Flushing—Tamoxifen—breast cancer	0.000989	0.00693	CcSEcCtD
Pancuronium—Rash—Lapatinib—breast cancer	0.000982	0.00688	CcSEcCtD
Pancuronium—Dermatitis—Lapatinib—breast cancer	0.000982	0.00688	CcSEcCtD
Pancuronium—SLC22A1—adipose tissue—breast cancer	0.000971	0.0298	CbGeAlD
Pancuronium—Flushing—Melphalan—breast cancer	0.000968	0.00678	CcSEcCtD
Pancuronium—Redness—Doxorubicin—breast cancer	0.000956	0.0067	CcSEcCtD
Pancuronium—Paralysis—Doxorubicin—breast cancer	0.000929	0.00651	CcSEcCtD
Pancuronium—Erythema—Tamoxifen—breast cancer	0.000927	0.0065	CcSEcCtD
Pancuronium—Muscular weakness—Fluorouracil—breast cancer	0.000918	0.00643	CcSEcCtD
Pancuronium—Hypersensitivity—Exemestane—breast cancer	0.000917	0.00643	CcSEcCtD
Pancuronium—Vecuronium—ABCB1—breast cancer	0.000916	0.294	CrCbGaD
Pancuronium—Rash—Fulvestrant—breast cancer	0.000904	0.00633	CcSEcCtD
Pancuronium—Dermatitis—Fulvestrant—breast cancer	0.000903	0.00633	CcSEcCtD
Pancuronium—Bronchospasm—Gemcitabine—breast cancer	0.0009	0.0063	CcSEcCtD
Pancuronium—Rash—Toremifene—breast cancer	0.000892	0.00625	CcSEcCtD
Pancuronium—Dermatitis—Toremifene—breast cancer	0.000891	0.00624	CcSEcCtD
Pancuronium—Erythema—Goserelin—breast cancer	0.000886	0.00621	CcSEcCtD
Pancuronium—Apnoea—Methotrexate—breast cancer	0.00088	0.00616	CcSEcCtD
Pancuronium—Hypersensitivity—Ixabepilone—breast cancer	0.000865	0.00606	CcSEcCtD
Pancuronium—Flushing—Vinorelbine—breast cancer	0.000846	0.00593	CcSEcCtD
Pancuronium—CHRNB1—lymph node—breast cancer	0.000829	0.0254	CbGeAlD
Pancuronium—Hypersensitivity—Anastrozole—breast cancer	0.000815	0.00571	CcSEcCtD
Pancuronium—CHRM3—adipose tissue—breast cancer	0.000805	0.0247	CbGeAlD
Pancuronium—Erythema—Vinorelbine—breast cancer	0.000793	0.00556	CcSEcCtD
Pancuronium—Rash—Exemestane—breast cancer	0.000785	0.0055	CcSEcCtD
Pancuronium—Dermatitis—Exemestane—breast cancer	0.000784	0.00549	CcSEcCtD
Pancuronium—Muscular weakness—Paclitaxel—breast cancer	0.000781	0.00548	CcSEcCtD
Pancuronium—Hypersensitivity—Idarubicin—breast cancer	0.000773	0.00542	CcSEcCtD
Pancuronium—BCHE—skin of body—breast cancer	0.000773	0.0237	CbGeAlD
Pancuronium—CHRM2—endocrine gland—breast cancer	0.000769	0.0236	CbGeAlD
Pancuronium—Respiratory failure—Methotrexate—breast cancer	0.000759	0.00532	CcSEcCtD
Pancuronium—Erythema—Thiotepa—breast cancer	0.000758	0.00531	CcSEcCtD
Pancuronium—SLC22A1—endocrine gland—breast cancer	0.000755	0.0232	CbGeAlD
Pancuronium—Anaphylactic shock—Melphalan—breast cancer	0.000741	0.00519	CcSEcCtD
Pancuronium—Rash—Ixabepilone—breast cancer	0.000741	0.00519	CcSEcCtD
Pancuronium—CHRM3—female reproductive system—breast cancer	0.00074	0.0227	CbGeAlD
Pancuronium—Dermatitis—Ixabepilone—breast cancer	0.00074	0.00518	CcSEcCtD
Pancuronium—BCHE—endometrium—breast cancer	0.000729	0.0224	CbGeAlD
Pancuronium—Tachycardia—Melphalan—breast cancer	0.000723	0.00507	CcSEcCtD
Pancuronium—Anaphylactic shock—Goserelin—breast cancer	0.000723	0.00507	CcSEcCtD
Pancuronium—Tachycardia—Goserelin—breast cancer	0.000706	0.00494	CcSEcCtD
Pancuronium—Flushing—Irinotecan—breast cancer	0.000698	0.00489	CcSEcCtD
Pancuronium—Rash—Letrozole—breast cancer	0.000697	0.00489	CcSEcCtD
Pancuronium—Rash—Anastrozole—breast cancer	0.000697	0.00489	CcSEcCtD
Pancuronium—Dermatitis—Anastrozole—breast cancer	0.000697	0.00488	CcSEcCtD
Pancuronium—Dermatitis—Letrozole—breast cancer	0.000697	0.00488	CcSEcCtD
Pancuronium—Hypotension—Melphalan—breast cancer	0.000692	0.00485	CcSEcCtD
Pancuronium—Salivary hypersecretion—Epirubicin—breast cancer	0.000678	0.00475	CcSEcCtD
Pancuronium—Hypotension—Goserelin—breast cancer	0.000675	0.00473	CcSEcCtD
Pancuronium—CHRM3—female gonad—breast cancer	0.000673	0.0207	CbGeAlD
Pancuronium—BCHE—uterus—breast cancer	0.000672	0.0206	CbGeAlD
Pancuronium—Rash—Idarubicin—breast cancer	0.000662	0.00464	CcSEcCtD
Pancuronium—Rash—Raloxifene—breast cancer	0.000662	0.00464	CcSEcCtD
Pancuronium—Dermatitis—Idarubicin—breast cancer	0.000661	0.00463	CcSEcCtD
Pancuronium—Dermatitis—Raloxifene—breast cancer	0.000661	0.00463	CcSEcCtD
Pancuronium—BCHE—pituitary gland—breast cancer	0.00066	0.0202	CbGeAlD
Pancuronium—BCHE—adipose tissue—breast cancer	0.000657	0.0202	CbGeAlD
Pancuronium—Erythema—Mitoxantrone—breast cancer	0.000654	0.00458	CcSEcCtD
Pancuronium—Anaphylactic shock—Vinorelbine—breast cancer	0.000647	0.00454	CcSEcCtD
Pancuronium—Muscular weakness—Capecitabine—breast cancer	0.000641	0.00449	CcSEcCtD
Pancuronium—Bronchospasm—Docetaxel—breast cancer	0.000638	0.00447	CcSEcCtD
Pancuronium—Erythema—Gemcitabine—breast cancer	0.000637	0.00447	CcSEcCtD
Pancuronium—Tachycardia—Vinorelbine—breast cancer	0.000632	0.00443	CcSEcCtD
Pancuronium—Salivary hypersecretion—Doxorubicin—breast cancer	0.000627	0.00439	CcSEcCtD
Pancuronium—Erythema—Fluorouracil—breast cancer	0.000627	0.00439	CcSEcCtD
Pancuronium—Hypersensitivity—Chlorambucil—breast cancer	0.000626	0.00439	CcSEcCtD
Pancuronium—CHRM3—endocrine gland—breast cancer	0.000626	0.0192	CbGeAlD
Pancuronium—Bronchospasm—Capecitabine—breast cancer	0.000618	0.00433	CcSEcCtD
Pancuronium—Hypotension—Vinorelbine—breast cancer	0.000605	0.00424	CcSEcCtD
Pancuronium—BCHE—female reproductive system—breast cancer	0.000604	0.0185	CbGeAlD
Pancuronium—Tachycardia—Thiotepa—breast cancer	0.000603	0.00423	CcSEcCtD
Pancuronium—BCHE—adrenal gland—breast cancer	0.000589	0.0181	CbGeAlD
Pancuronium—Hypersensitivity—Vinblastine—breast cancer	0.000574	0.00402	CcSEcCtD
Pancuronium—BCHE—bone marrow—breast cancer	0.00057	0.0175	CbGeAlD
Pancuronium—Flushing—Paclitaxel—breast cancer	0.000569	0.00399	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Methotrexate—breast cancer	0.000559	0.00392	CcSEcCtD
Pancuronium—Hypersensitivity—Tamoxifen—breast cancer	0.000558	0.00391	CcSEcCtD
Pancuronium—Hypersensitivity—Melphalan—breast cancer	0.000546	0.00383	CcSEcCtD
Pancuronium—Anaphylactic shock—Mitoxantrone—breast cancer	0.000534	0.00374	CcSEcCtD
Pancuronium—Anaphylactic shock—Irinotecan—breast cancer	0.000534	0.00374	CcSEcCtD
Pancuronium—Erythema—Paclitaxel—breast cancer	0.000534	0.00374	CcSEcCtD
Pancuronium—Hypersensitivity—Goserelin—breast cancer	0.000533	0.00373	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Epirubicin—breast cancer	0.000523	0.00367	CcSEcCtD
Pancuronium—Tachycardia—Mitoxantrone—breast cancer	0.000521	0.00365	CcSEcCtD
Pancuronium—Anaphylactic shock—Gemcitabine—breast cancer	0.00052	0.00364	CcSEcCtD
Pancuronium—Anaphylactic shock—Fluorouracil—breast cancer	0.000511	0.00358	CcSEcCtD
Pancuronium—BCHE—endocrine gland—breast cancer	0.000511	0.0157	CbGeAlD
Pancuronium—Tachycardia—Fluorouracil—breast cancer	0.000499	0.0035	CcSEcCtD
Pancuronium—Hypotension—Irinotecan—breast cancer	0.000499	0.0035	CcSEcCtD
Pancuronium—Hypotension—Mitoxantrone—breast cancer	0.000499	0.0035	CcSEcCtD
Pancuronium—Hypotension—Gemcitabine—breast cancer	0.000486	0.00341	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Doxorubicin—breast cancer	0.000484	0.00339	CcSEcCtD
Pancuronium—Flushing—Docetaxel—breast cancer	0.000482	0.00338	CcSEcCtD
Pancuronium—Hypotension—Fluorouracil—breast cancer	0.000478	0.00335	CcSEcCtD
Pancuronium—Rash—Tamoxifen—breast cancer	0.000477	0.00334	CcSEcCtD
Pancuronium—Hypersensitivity—Vinorelbine—breast cancer	0.000477	0.00334	CcSEcCtD
Pancuronium—Dermatitis—Tamoxifen—breast cancer	0.000477	0.00334	CcSEcCtD
Pancuronium—Rash—Melphalan—breast cancer	0.000467	0.00327	CcSEcCtD
Pancuronium—Flushing—Capecitabine—breast cancer	0.000467	0.00327	CcSEcCtD
Pancuronium—Dermatitis—Melphalan—breast cancer	0.000467	0.00327	CcSEcCtD
Pancuronium—Rash—Goserelin—breast cancer	0.000456	0.00319	CcSEcCtD
Pancuronium—Hypersensitivity—Thiotepa—breast cancer	0.000456	0.00319	CcSEcCtD
Pancuronium—Dermatitis—Goserelin—breast cancer	0.000455	0.00319	CcSEcCtD
Pancuronium—Erythema—Docetaxel—breast cancer	0.000452	0.00317	CcSEcCtD
Pancuronium—Muscular weakness—Epirubicin—breast cancer	0.000447	0.00313	CcSEcCtD
Pancuronium—Erythema—Capecitabine—breast cancer	0.000438	0.00307	CcSEcCtD
Pancuronium—Anaphylactic shock—Paclitaxel—breast cancer	0.000435	0.00305	CcSEcCtD
Pancuronium—Tachycardia—Paclitaxel—breast cancer	0.000425	0.00298	CcSEcCtD
Pancuronium—Muscular weakness—Doxorubicin—breast cancer	0.000413	0.0029	CcSEcCtD
Pancuronium—Rash—Vinorelbine—breast cancer	0.000408	0.00286	CcSEcCtD
Pancuronium—Dermatitis—Vinorelbine—breast cancer	0.000408	0.00286	CcSEcCtD
Pancuronium—Hypotension—Paclitaxel—breast cancer	0.000407	0.00285	CcSEcCtD
Pancuronium—Hypersensitivity—Irinotecan—breast cancer	0.000393	0.00276	CcSEcCtD
Pancuronium—Hypersensitivity—Mitoxantrone—breast cancer	0.000393	0.00276	CcSEcCtD
Pancuronium—Rash—Thiotepa—breast cancer	0.00039	0.00273	CcSEcCtD
Pancuronium—Dermatitis—Thiotepa—breast cancer	0.000389	0.00273	CcSEcCtD
Pancuronium—Hypersensitivity—Fluorouracil—breast cancer	0.000377	0.00264	CcSEcCtD
Pancuronium—Anaphylactic shock—Docetaxel—breast cancer	0.000369	0.00259	CcSEcCtD
Pancuronium—Tachycardia—Docetaxel—breast cancer	0.00036	0.00252	CcSEcCtD
Pancuronium—BCHE—lymph node—breast cancer	0.000353	0.0108	CbGeAlD
Pancuronium—Tachycardia—Capecitabine—breast cancer	0.000349	0.00244	CcSEcCtD
Pancuronium—Hypotension—Docetaxel—breast cancer	0.000345	0.00242	CcSEcCtD
Pancuronium—Rash—Mitoxantrone—breast cancer	0.000337	0.00236	CcSEcCtD
Pancuronium—Rash—Irinotecan—breast cancer	0.000337	0.00236	CcSEcCtD
Pancuronium—Dermatitis—Irinotecan—breast cancer	0.000336	0.00236	CcSEcCtD
Pancuronium—Dermatitis—Mitoxantrone—breast cancer	0.000336	0.00236	CcSEcCtD
Pancuronium—Hypotension—Capecitabine—breast cancer	0.000334	0.00234	CcSEcCtD
Pancuronium—Rash—Gemcitabine—breast cancer	0.000328	0.0023	CcSEcCtD
Pancuronium—Dermatitis—Gemcitabine—breast cancer	0.000328	0.0023	CcSEcCtD
Pancuronium—Erythema—Methotrexate—breast cancer	0.000326	0.00228	CcSEcCtD
Pancuronium—Flushing—Epirubicin—breast cancer	0.000325	0.00228	CcSEcCtD
Pancuronium—Rash—Fluorouracil—breast cancer	0.000322	0.00226	CcSEcCtD
Pancuronium—Dermatitis—Fluorouracil—breast cancer	0.000322	0.00226	CcSEcCtD
Pancuronium—Hypersensitivity—Paclitaxel—breast cancer	0.000321	0.00225	CcSEcCtD
Pancuronium—Erythema—Epirubicin—breast cancer	0.000305	0.00214	CcSEcCtD
Pancuronium—Flushing—Doxorubicin—breast cancer	0.000301	0.00211	CcSEcCtD
Pancuronium—Erythema—Doxorubicin—breast cancer	0.000282	0.00198	CcSEcCtD
Pancuronium—Rash—Paclitaxel—breast cancer	0.000275	0.00192	CcSEcCtD
Pancuronium—Dermatitis—Paclitaxel—breast cancer	0.000274	0.00192	CcSEcCtD
Pancuronium—Hypersensitivity—Docetaxel—breast cancer	0.000272	0.00191	CcSEcCtD
Pancuronium—Anaphylactic shock—Methotrexate—breast cancer	0.000266	0.00186	CcSEcCtD
Pancuronium—Hypersensitivity—Capecitabine—breast cancer	0.000263	0.00184	CcSEcCtD
Pancuronium—Anaphylactic shock—Epirubicin—breast cancer	0.000249	0.00174	CcSEcCtD
Pancuronium—Hypotension—Methotrexate—breast cancer	0.000249	0.00174	CcSEcCtD
Pancuronium—Tachycardia—Epirubicin—breast cancer	0.000243	0.0017	CcSEcCtD
Pancuronium—Rash—Docetaxel—breast cancer	0.000233	0.00163	CcSEcCtD
Pancuronium—Hypotension—Epirubicin—breast cancer	0.000233	0.00163	CcSEcCtD
Pancuronium—Dermatitis—Docetaxel—breast cancer	0.000233	0.00163	CcSEcCtD
Pancuronium—Anaphylactic shock—Doxorubicin—breast cancer	0.00023	0.00161	CcSEcCtD
Pancuronium—Rash—Capecitabine—breast cancer	0.000225	0.00158	CcSEcCtD
Pancuronium—Dermatitis—Capecitabine—breast cancer	0.000225	0.00158	CcSEcCtD
Pancuronium—Tachycardia—Doxorubicin—breast cancer	0.000225	0.00158	CcSEcCtD
Pancuronium—Hypotension—Doxorubicin—breast cancer	0.000215	0.00151	CcSEcCtD
Pancuronium—Hypersensitivity—Methotrexate—breast cancer	0.000196	0.00137	CcSEcCtD
Pancuronium—Hypersensitivity—Epirubicin—breast cancer	0.000183	0.00129	CcSEcCtD
Pancuronium—Hypersensitivity—Doxorubicin—breast cancer	0.00017	0.00119	CcSEcCtD
Pancuronium—Rash—Methotrexate—breast cancer	0.000168	0.00118	CcSEcCtD
Pancuronium—Dermatitis—Methotrexate—breast cancer	0.000168	0.00117	CcSEcCtD
Pancuronium—Rash—Epirubicin—breast cancer	0.000157	0.0011	CcSEcCtD
Pancuronium—Dermatitis—Epirubicin—breast cancer	0.000157	0.0011	CcSEcCtD
Pancuronium—Rash—Doxorubicin—breast cancer	0.000145	0.00102	CcSEcCtD
Pancuronium—Dermatitis—Doxorubicin—breast cancer	0.000145	0.00102	CcSEcCtD
Pancuronium—CHRM2—Signaling Pathways—TCF7L2—breast cancer	1.46e-05	0.00011	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—PIK3CG—breast cancer	1.45e-05	0.00011	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—AKT2—breast cancer	1.45e-05	0.00011	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—PIK3CG—breast cancer	1.44e-05	0.000109	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—GPX1—breast cancer	1.43e-05	0.000109	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—ABCB1—breast cancer	1.43e-05	0.000108	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—MTHFR—breast cancer	1.42e-05	0.000108	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—CYP1A1—breast cancer	1.42e-05	0.000108	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—HSP90AA1—breast cancer	1.42e-05	0.000108	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—NOTCH2—breast cancer	1.42e-05	0.000108	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—ERCC2—breast cancer	1.41e-05	0.000107	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—PIK3CD—breast cancer	1.41e-05	0.000107	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—NOTCH2—breast cancer	1.41e-05	0.000107	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—HSP90AA1—breast cancer	1.41e-05	0.000107	CbGpPWpGaD
Pancuronium—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.4e-05	0.000106	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—TYMS—breast cancer	1.4e-05	0.000106	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—PIK3CD—breast cancer	1.39e-05	0.000106	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—NCOR1—breast cancer	1.38e-05	0.000105	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PLA2G4A—breast cancer	1.38e-05	0.000105	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—GSTM1—breast cancer	1.38e-05	0.000105	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PRL—breast cancer	1.38e-05	0.000105	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—AGTR1—breast cancer	1.38e-05	0.000105	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PRL—breast cancer	1.37e-05	0.000104	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—AGTR1—breast cancer	1.37e-05	0.000104	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—ADAM10—breast cancer	1.36e-05	0.000103	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—STK11—breast cancer	1.36e-05	0.000103	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—ADAM10—breast cancer	1.35e-05	0.000102	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—STK11—breast cancer	1.35e-05	0.000102	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PLG—breast cancer	1.35e-05	0.000102	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PIK3CG—breast cancer	1.34e-05	0.000101	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PLG—breast cancer	1.33e-05	0.000101	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—AKT2—breast cancer	1.33e-05	0.000101	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—GPX1—breast cancer	1.33e-05	0.0001	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—MTHFR—breast cancer	1.32e-05	0.0001	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—FGF10—breast cancer	1.32e-05	0.0001	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—AKT2—breast cancer	1.32e-05	9.99e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—CYP1A1—breast cancer	1.31e-05	9.94e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—FGF10—breast cancer	1.31e-05	9.93e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—CAV1—breast cancer	1.31e-05	9.93e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—ERCC2—breast cancer	1.3e-05	9.86e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—PIK3CD—breast cancer	1.28e-05	9.69e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PDGFA—breast cancer	1.28e-05	9.68e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—PIK3CD—breast cancer	1.27e-05	9.6e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PDGFA—breast cancer	1.26e-05	9.59e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—TGFBR2—breast cancer	1.26e-05	9.54e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—TGFBR2—breast cancer	1.25e-05	9.45e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—ITPR1—breast cancer	1.24e-05	9.39e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—ERBB4—breast cancer	1.23e-05	9.33e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—STAT5A—breast cancer	1.23e-05	9.33e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—MMP3—breast cancer	1.23e-05	9.33e-05	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—PIK3CB—breast cancer	1.23e-05	9.3e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—ITPR1—breast cancer	1.23e-05	9.3e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—MTHFR—breast cancer	1.22e-05	9.27e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—CAV1—breast cancer	1.22e-05	9.25e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—ERBB4—breast cancer	1.22e-05	9.24e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—MMP3—breast cancer	1.22e-05	9.24e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—STAT5A—breast cancer	1.22e-05	9.24e-05	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—PIK3CB—breast cancer	1.22e-05	9.21e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PIK3CG—breast cancer	1.19e-05	9.04e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—SMAD4—breast cancer	1.19e-05	9.03e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—IGF1R—breast cancer	1.18e-05	8.98e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—SMAD4—breast cancer	1.18e-05	8.94e-05	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—CXCL8—breast cancer	1.18e-05	8.94e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PIK3CD—breast cancer	1.17e-05	8.9e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—IGF1R—breast cancer	1.17e-05	8.89e-05	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—CXCL8—breast cancer	1.17e-05	8.85e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—HES1—breast cancer	1.16e-05	8.82e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—ALB—breast cancer	1.16e-05	8.79e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PLA2G4A—breast cancer	1.16e-05	8.77e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—NCOR1—breast cancer	1.16e-05	8.77e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—HES1—breast cancer	1.15e-05	8.73e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—NCOR1—breast cancer	1.15e-05	8.68e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PLA2G4A—breast cancer	1.15e-05	8.68e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CSF2—breast cancer	1.14e-05	8.67e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—FGF1—breast cancer	1.14e-05	8.67e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—RAF1—breast cancer	1.14e-05	8.65e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—NRG1—breast cancer	1.14e-05	8.61e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—FGF1—breast cancer	1.13e-05	8.59e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CSF2—breast cancer	1.13e-05	8.59e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—RAF1—breast cancer	1.13e-05	8.57e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—CAV1—breast cancer	1.13e-05	8.55e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—H2AFX—breast cancer	1.13e-05	8.55e-05	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—IL2—breast cancer	1.13e-05	8.54e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—NRG1—breast cancer	1.12e-05	8.52e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—E2F1—breast cancer	1.12e-05	8.48e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—H2AFX—breast cancer	1.12e-05	8.46e-05	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—IL2—breast cancer	1.12e-05	8.46e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—PIK3CB—breast cancer	1.11e-05	8.45e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PIK3CG—breast cancer	1.11e-05	8.43e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—NOS3—breast cancer	1.11e-05	8.41e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—E2F1—breast cancer	1.11e-05	8.4e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—PIK3CB—breast cancer	1.1e-05	8.36e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—SPP1—breast cancer	1.08e-05	8.15e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—CXCL8—breast cancer	1.07e-05	8.12e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—SPP1—breast cancer	1.07e-05	8.07e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—ERBB3—breast cancer	1.06e-05	8.06e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—FGFR2—breast cancer	1.06e-05	8.05e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—CXCL8—breast cancer	1.06e-05	8.04e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—ERBB3—breast cancer	1.05e-05	7.98e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—FGFR2—breast cancer	1.05e-05	7.97e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PIK3CD—breast cancer	1.05e-05	7.95e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—ALB—breast cancer	1.04e-05	7.85e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PIK3CG—breast cancer	1.03e-05	7.79e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PIK3CB—breast cancer	1.02e-05	7.76e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—IL2—breast cancer	1.02e-05	7.76e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—TERT—breast cancer	1.02e-05	7.73e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PTGS2—breast cancer	1.01e-05	7.69e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—IL2—breast cancer	1.01e-05	7.68e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—TERT—breast cancer	1.01e-05	7.65e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—NOS3—breast cancer	9.91e-06	7.51e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—FGFR1—breast cancer	9.9e-06	7.5e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—FGFR1—breast cancer	9.81e-06	7.43e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PIK3CD—breast cancer	9.78e-06	7.41e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—HIF1A—breast cancer	9.75e-06	7.39e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—HIF1A—breast cancer	9.66e-06	7.32e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—ALB—breast cancer	9.65e-06	7.32e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—LEP—breast cancer	9.52e-06	7.21e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CAV1—breast cancer	9.43e-06	7.15e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—LEP—breast cancer	9.43e-06	7.14e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CAV1—breast cancer	9.34e-06	7.08e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—KDR—breast cancer	9.33e-06	7.07e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—KDR—breast cancer	9.24e-06	7e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—NOS3—breast cancer	9.23e-06	7e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PIK3CB—breast cancer	9.14e-06	6.93e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—ESR1—breast cancer	9.09e-06	6.89e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PTGS2—breast cancer	9.06e-06	6.87e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PIK3CD—breast cancer	9.03e-06	6.85e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—ESR1—breast cancer	9e-06	6.82e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—FN1—breast cancer	8.98e-06	6.8e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—ALB—breast cancer	8.92e-06	6.76e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—FN1—breast cancer	8.89e-06	6.74e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—NFKBIA—breast cancer	8.87e-06	6.72e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PTEN—breast cancer	8.85e-06	6.7e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—NOTCH1—breast cancer	8.79e-06	6.66e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—NFKBIA—breast cancer	8.79e-06	6.66e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—NOTCH1—breast cancer	8.7e-06	6.59e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—APC—breast cancer	8.59e-06	6.51e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PIK3CG—breast cancer	8.59e-06	6.51e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—KIT—breast cancer	8.59e-06	6.51e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—NOS3—breast cancer	8.53e-06	6.46e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PIK3CB—breast cancer	8.52e-06	6.46e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—APC—breast cancer	8.51e-06	6.45e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PIK3CG—breast cancer	8.51e-06	6.45e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—KIT—breast cancer	8.51e-06	6.45e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—EGF—breast cancer	8.49e-06	6.44e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PTGS2—breast cancer	8.45e-06	6.4e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—EGF—breast cancer	8.41e-06	6.37e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—MAPK3—breast cancer	8.23e-06	6.24e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—MAPK3—breast cancer	8.15e-06	6.18e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—BRAF—breast cancer	8.08e-06	6.12e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—BRAF—breast cancer	8e-06	6.06e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PTEN—breast cancer	7.9e-06	5.99e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PIK3CB—breast cancer	7.87e-06	5.97e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—IGF1—breast cancer	7.87e-06	5.96e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—AKT2—breast cancer	7.86e-06	5.96e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—EGFR—breast cancer	7.83e-06	5.93e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PTGS2—breast cancer	7.8e-06	5.91e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—IGF1—breast cancer	7.79e-06	5.9e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—AKT2—breast cancer	7.78e-06	5.9e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—EGFR—breast cancer	7.75e-06	5.87e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PIK3CD—breast cancer	7.55e-06	5.72e-05	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—PIK3CA—breast cancer	7.48e-06	5.67e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PIK3CD—breast cancer	7.48e-06	5.67e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—SERPINE1—breast cancer	7.47e-06	5.66e-05	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—PIK3CA—breast cancer	7.41e-06	5.61e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—SERPINE1—breast cancer	7.4e-06	5.61e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—KRAS—breast cancer	7.39e-06	5.6e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PTEN—breast cancer	7.37e-06	5.58e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—KRAS—breast cancer	7.32e-06	5.55e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—NOS3—breast cancer	7.13e-06	5.4e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—NOS3—breast cancer	7.06e-06	5.35e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PTEN—breast cancer	6.8e-06	5.16e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—PIK3CA—breast cancer	6.79e-06	5.15e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—MDM2—breast cancer	6.77e-06	5.13e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—RAF1—breast cancer	6.74e-06	5.11e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—PIK3CA—breast cancer	6.73e-06	5.1e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—RELA—breast cancer	6.71e-06	5.09e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—MDM2—breast cancer	6.7e-06	5.08e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—RAF1—breast cancer	6.68e-06	5.06e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—ERBB2—breast cancer	6.67e-06	5.06e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—RELA—breast cancer	6.65e-06	5.04e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—ERBB2—breast cancer	6.61e-06	5.01e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—MTOR—breast cancer	6.58e-06	4.99e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PIK3CB—breast cancer	6.58e-06	4.99e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—MTOR—breast cancer	6.52e-06	4.94e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PIK3CB—breast cancer	6.52e-06	4.94e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CXCL8—breast cancer	6.33e-06	4.79e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—HRAS—breast cancer	6.29e-06	4.76e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CXCL8—breast cancer	6.27e-06	4.75e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PIK3CA—breast cancer	6.24e-06	4.73e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—HRAS—breast cancer	6.22e-06	4.72e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CDKN1B—breast cancer	6.18e-06	4.68e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CDKN1B—breast cancer	6.12e-06	4.64e-05	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—AKT1—breast cancer	6.11e-06	4.63e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CASP3—breast cancer	6.06e-06	4.59e-05	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—AKT1—breast cancer	6.05e-06	4.59e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—IL2—breast cancer	6.05e-06	4.58e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—IL6—breast cancer	6.02e-06	4.56e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CASP3—breast cancer	6e-06	4.54e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—IL2—breast cancer	5.99e-06	4.54e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—IL6—breast cancer	5.96e-06	4.51e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CCND1—breast cancer	5.89e-06	4.47e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—JUN—breast cancer	5.88e-06	4.46e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CCND1—breast cancer	5.84e-06	4.42e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CTNNB1—breast cancer	5.84e-06	4.42e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—JUN—breast cancer	5.82e-06	4.41e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CTNNB1—breast cancer	5.78e-06	4.38e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—MMP9—breast cancer	5.72e-06	4.34e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CDKN1A—breast cancer	5.7e-06	4.32e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PTEN—breast cancer	5.69e-06	4.31e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—MMP9—breast cancer	5.67e-06	4.29e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CDKN1A—breast cancer	5.65e-06	4.28e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PTEN—breast cancer	5.63e-06	4.27e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PIK3CA—breast cancer	5.57e-06	4.22e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—MAPK8—breast cancer	5.57e-06	4.22e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—AKT1—breast cancer	5.55e-06	4.21e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—MAPK8—breast cancer	5.51e-06	4.18e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—AKT1—breast cancer	5.5e-06	4.17e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—SRC—breast cancer	5.28e-06	4e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—SRC—breast cancer	5.22e-06	3.96e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PIK3CA—breast cancer	5.2e-06	3.94e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—VEGFA—breast cancer	5.14e-06	3.89e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—AKT1—breast cancer	5.1e-06	3.86e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—VEGFA—breast cancer	5.09e-06	3.86e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—STAT3—breast cancer	5.09e-06	3.86e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—STAT3—breast cancer	5.04e-06	3.82e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—MAPK3—breast cancer	4.86e-06	3.68e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—MAPK3—breast cancer	4.81e-06	3.65e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PIK3CA—breast cancer	4.8e-06	3.64e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—MYC—breast cancer	4.73e-06	3.58e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—TGFB1—breast cancer	4.72e-06	3.57e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—MYC—breast cancer	4.68e-06	3.55e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—TGFB1—breast cancer	4.67e-06	3.54e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—EGFR—breast cancer	4.62e-06	3.5e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—EGFR—breast cancer	4.58e-06	3.47e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—AKT1—breast cancer	4.55e-06	3.45e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—KRAS—breast cancer	4.37e-06	3.31e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—KRAS—breast cancer	4.33e-06	3.28e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—AKT1—breast cancer	4.24e-06	3.22e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PIK3CA—breast cancer	4.01e-06	3.04e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PIK3CA—breast cancer	3.97e-06	3.01e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—AKT1—breast cancer	3.92e-06	2.97e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—TP53—breast cancer	3.88e-06	2.94e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—TP53—breast cancer	3.84e-06	2.91e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—HRAS—breast cancer	3.71e-06	2.81e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—HRAS—breast cancer	3.68e-06	2.79e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—IL6—breast cancer	3.55e-06	2.69e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—IL6—breast cancer	3.52e-06	2.67e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—AKT1—breast cancer	3.28e-06	2.48e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—AKT1—breast cancer	3.25e-06	2.46e-05	CbGpPWpGaD
